Latest News Archive
Please select Category, Year, and then Month to display items
31 January 2018
Photo FNB Varsity Cup
Lubabalo Dobela, Shimlas flyhalf (with the ball), played a key role in the Shimlas’ win over Tuks in the first round of the 2018 Varsity Cup.
The Shimlas made a huge statement in their opening match of the 2018 Varsity Cup when they defeated last year’s champions at the Tuks Rugby Stadium in Pretoria.
The Free State students won the encounter against Tuks by 19-17 on Monday.
Tuks, who beat Shimlas twice last year, first in the group stage by 65-19, and then by 28-21 in the semifinals, were regarded as the hot favourites. The match was played in wet conditions which many thought would suit the home team better.
Determination carries team to win
But a young and inexperienced Shimlas team with 11 players making their debut in the competition proved that big hearts and guts count for just as much. It was only their third win in Pretoria in the 11th year of the competition and their second victory over Tuks since 2012.
As expected, both teams tightened up their approach. Shimlas struck back from a 0-5 deficit soon after the first strategy break as big and speedy wing Francois Agenbag stormed down the touchline to score a seven-point try. Flyhalf Lubabalo Dobela was on hand to convert and hand his team a 9-5 lead at the break.
Flyhalf stars in debut
The Shimlas extended their lead within five minutes of the restart as flank Benji Janse van Vuuren crashed over in the corner for a converted try. Dobela, one of the debutants who was named Player that Rocks (Player of the Match), controlled the match like a seasoned veteran. Apart from two difficult conversions from the touchline, he also slotted a penalty goal.
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology